Hinge Health

Hinge Health EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Hinge Health (HNGE) as of Nov 14, 2026 is -4.96. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -81.79 — a change of -93.94% (higher).

EV/EBITDA

-4.96

YoY

-93.94%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Hinge Health is 2025 -4.96 . EV/EBITDA (Enterprise Value to EBITDA) of Hinge Health was 2024 -81.79 . It decreases by -93.94% higher compared to the previous year.

The Hinge Health EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2023
-20.36 USD
Jan 1, 2024
-81.79 USD
Jan 1, 2025
-4.96 USD
The Hinge Health EV/EBITDA history
YEAREV/EBITDAYoY
-4.96-93.94%
-81.79+301.64%
-20.36—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hinge Health Stock analysis

What does Hinge Health do? Hinge Health, Inc. generates revenue through its TrueMotion platform, which provides AI-powered motion tracking for musculoskeletal care. The platform delivers personalized care programs covering prevention, acute injury treatment, chronic pain management, and post-surgical rehabilitation. Members access these services via the TrueMotion platform, which integrates with the Enso wearable device offering electrical nerve stimulation for pain relief. The company's AI-supported care team of licensed physical therapists, physicians, and health coaches monitors and adjusts care plans. Hinge Health's primary customers are employers and health plans that purchase the platform for their members, with the Enso device sold as an add-on to the platform subscription. The TrueMotion platform is designed for a spectrum of MSK care needs, from acute injury to chronic pain, and includes surgery decision support and post-surgical recovery programs. Enso, the electrical nerve stimulation wearable, is sold as a complementary product to enhance pain management within the platform's care continuum. The company's revenue model combines platform subscriptions with device sales, targeting employer and health plan segments that seek to reduce healthcare costs through proactive MSK management. Hinge Health's care team provides ongoing support through the AI-enhanced platform, ensuring continuous engagement and personalized care delivery. Hinge Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hinge Health stock

EV/EBITDA (Enterprise Value to EBITDA) of Hinge Health is -4.96 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Hinge Health changed from -81.79 to -4.96, representing a -93.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Hinge Health since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Hinge Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Hinge Health

All Key Metrics — Hinge Health